Monitoring risk behaviour in adolescent pupils regarding consumption of psychoactive substances
More details
Hide details
Department of Physiology, University of Medical Sciences, Poznan, Poland
Higher Vocational State School, Kalisz, Poland
Department of Hygiene, Poznan University of Medical Sciences, Poznan, Poland
Department of Molecular Biology and Translational Research, Institute of Rural Health, Lublin, Poland
Chair of Medical Biology and Translational Research Faculty of Medicine, University of Information Technology and Management, Rzeszow, Poland
Institute of Electrical Engineering and Electrotechnologies, Faculty of Electrical Engineering and Computer Science Lublin University of Technology, Poland
Chair and Department of Facility Management Organizations in Health Care, University of Medical Sciences, Poznan, Poland
Department of Emergency Medicine, Poznan University of Medical Sciences, Poznan, Poland
Ann Agric Environ Med. 2017;24(2):350–355
Taking psychoactive substances constitutes a significant problem for Public Health, particularly in preventing drug abuse and addiction.

To estimate the amount and incidence of drug consumption in middle and high school pupils, including the circumstances in which drug taking first started, and to determine pupils’ knowledge about the consequences of taking psychoactive substances and designer drugs (DDs).

Material and Methods:
A randomised study was conducted throughout Poland on 9,360 pupils attending middle school (junior high school) in 2009 and 7,971 pupils from middle and high school pupils in 2011. The survey consisted of a questionnaire devised by the Chief Sanitary Inspectorate (GIS) and the replies obtained were subject to the relevant statistical analyses.

Drug taking was found to have increased between 2009–2011, especially among those attending high school; proportionally rising from 4% – 11%. The numbers who had ever taken designer drugs were 3% for middle school pupils and 4% from high school.

World Drug Report 2012, UNODC, Nowy Jork 2012. analysis/WDR2012/WDR_2012_web_small.pdf (accessed: 2014.04.07).
Sierosławski J. Studenci 2004. Raport z badania ankietowego na temat używania substancji psychoaktywnych przez studentów (Students 2004. Survey report on the use of psychoactive substances by students). http:// (accessed: 2014.04.07) (in Polish).
Ustawa z dnia 29 lipca 2005 r. o przeciwdziałaniu narkomanii, Dziennik Ustaw z 2012 r. poz. 124, z późn. zm. (Act of 29 July 2005 amending the act on counteracting drug addiction, JL 2012 item. 124) (in Polish).
Pilling K. Hospital warning over „legal highs”. (accessed: 2014.04.07).
Brandt SD, Sumnall HR, Measham F, Cole J. Analyses of second-generation „legal highs” in the UK: The confusing case of NRG-1. Drug Test Anal 2010; 2(8) : 377–82.
Schmidt MM, Sharma A, Schifano F, Feinmann C. „Legal highs” on the net-evaluation of UK-based websites, products and product information. Forensic Sci Int. 2011; 206(1–3): 92–97.
Vardakou I, Pistos C, Spiliopoulou Ch. Spice drugs as a new trend: Mode of action, identification and legislation. Toxicol Lett. 2010; 197(3): 157–62.
Stan problemu narkotykowego w Europie (The state of the drugs problem in Europe). Sprawozdanie roczne 2008. EMCDDA, Urząd Oficjalnych Publikacji Wspólnot Europejskich, Luksemburg 2008. (accessed: 2014.04.07) (in Polish).
Eliott S, Smith C. Investigation of the first deaths in the United Kingdom involving the detection and quantitation of the piperazines BZP and 3-TFMP. J Anal Toxicol. 2008; 32(2): 172–77.
Wood DM, Dargan PI, Button J, Holt DW, Ovaska H, Ramsey J, et al. Collapse, reported seizure and an unexpected pill. Lancet 2007; 369(9571): 1490.
Biliński P, Hołownia P, Kapka-Skrzypczak L, Wojtyła A. Designer Drug (DD) abuse in Poland; a review of the psychoactive and toxic properties of substances found from seizures of illegal drug products and the legal consequences thereof. Part 1 – Cannabinoids and Cathinones. Ann Agric Environ Med. 2012; 19(4): 857–70.
Biliński P, Hołownia P, Kapka-Skrzypczak L, Wojtyła A. Designer Drug (DD) abuse in Poland; a review of the psychoactive and toxic properties of substances found from seizures of illegal drug products and the legal consequences thereof. Part II – Piperazines/Piperidines, Phenylethylamines, Tryptamines and miscellaneous ‘Others. Ann Agric Environ Med. 2012; 19(4): 871–82.
Kapka-Skrzypczak L, Cyranka M, Wojtyła A. Legal highs as an urgent issue of public health. Pol J Public Health 2011(2): 174–80 (in Polish).
Kapka-Skrzypczak L, Kulpa P, Sawicki K, Cyranka M, Wojtyła A, Kruszewski M. Legal highs – legal aspects and legislative solutions. Ann Agric Environ Med. 2011; 18(2): 304–9.
Hughes B, Winstock AR. Controlling new drugs under marketing regulations. Addiction. 2012; 107(11): 1894–9.
Biliński P, Kapka-Skrzypczak L, Jabłoński P. Determining the scale of designer drugs (DD) abuse and risk to public health in Poland through an epidemiological study in adolescents. Ann Agric Environ Med. 2012; 19(3): 357–64.
The ESPAD Raport 2011. Alcohol and other drug use among students in 36 European Countries. (accessed: 2014.04.07).
Jabłoński P, Bukowska B, Malczewski A (ed.). Raport krajowy 2009: Sytuacja narkotykowa w Polsce, (2009 National Report: Narcotics Situation in Poland), Krajowe Biuro ds. Przeciwdziałania Narkomanii, Warsaw 2009 (in Polish).
Pawłowska B, Zygo M, Potembska E, Kapka-Skrzypczak L, Dreher P, Kędzierski Z. Psychoactive substances use experience and addiction or risk of addiction among by Polish adolescents living in rural and urban areas. Ann Agric Environ Med. 2014; 21(4): 776–82.
Hassen GW, Ghobadi F, Kalantari H. Synthetic drugs: a new trend and the hidden danger. Am J Emerg Med. 2013; 31(9): 1413–5.
Łukasik-Głębocka M, Sommerfeld K, Nawrocka K. Legal highs toxicity- symptomatology and clinical diagnosis in case series. Przegl Lek. 2010; 67(8): 613–16 (in Polish).
Jędrzejko M, Neroj A, Wojcieszek K, Kowalewska A. Teorie uzależnień od substancji psychoaktywnych (Theories of addiction to psycho active substances). Współczesne teorie uzależnień od substancji psychoaktywnych (Contemporary theories of addiction to psychoactive substances). Jędrzejko M (red.) Akademia Humanistyczna im. A. Gieysztora-Oficyna Wydawnicza ASPRA-JR, Pułtusk-Warszawa 2009. p. 77–155 (in Polish).
Wojtyła-Buciora P, Wojtyła C, Urbaniak M, Kapka-Skrzypczak L, Wojtyła A, Diatczyk J, et al. Alcohol consumption in Polish middle and high school pupils-has this rapidly increased during 2009–11?. Ann Agric Environ Med. 2014; 21(3): 552–6.
Morawska-Siudak J, Szkolnicka B, Gomółka E, Krawczyk-Pasławska E. Designer drugs-diagnostic, psychological and low aspects of problem. Przegl Lek. 2010; 67(8): 598–601 (in Polish).
Biliński P, Wojtyła A, Kapka-Skrzypczak L, Chwedorowicz R, Cyranka M, Studziński T. Epigenetic regulation in drug addiction. Ann Agric Environ Med. 2012; 19(3): 491–6.
Kidawa M. Politoksykomania (Polytoxicomania). Remedium, 2008; 11: 28–29 (in Polish).
Warecki K. Dopalacze (Desiner drugs). Polskie Wydawnictwo Encyklopedyczne. Radom 2010 (in Polish).
Davies S, Wood DM, Smith G, Button J, Ramsey J, Archer R, et al. Purchasing “legal highs” on the Internet – is there consistency in what you get? QJM. 2010; 103(7): 489–93.
Zakrzewski T. Dopalacze w Internecie – marketing w służbie sprzedaży “środków zastępczych” w sieci (Boosters in Internet – marketing on sell-service “alternative means”). (accessed: 2014.04.07) (in Polish).
Vardakou I, Pistos C, Spiliopoulou Ch. Drugs for youth via Internet and the example of mephedrone. Toxicol Lett. 2011; 201(3): 191–5.
Wood DM, Hunter L, Measham F, Dargan PI. Limited use of novel psychoactive substances in South London nightclubs. OJM. 2012; 105(10): 959–64.
Motyka M. Psychoactive substances among young people of secondary schools in Przemysl. Probl Hig Epidemiol. 2013; 94(2): 205–14 (in Polish).
Garus-Pakowska A, Drozdowska M, Moczulski R. Knowledge on psychoactive substances among students of selected Lodz universities. Part II. Probl Hig Epidemiol. 2012; 93(2): 356–62 (in Polish).
34. (accessed: 2014.04.07).